Affymax Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Net Income before Extraordinaries
76,531.00
14,075.00
61,367.00
93,412.00
14,424.00
Depreciation, Depletion & Amortization
2,116.00
2,212.00
2,182.00
1,987.00
722.00
Other Funds
11,166.00
12,175.00
10,091.00
57,100.00
36,361.00
Funds from Operations
63,249.00
312.00
49,094.00
34,325.00
50,063.00
Changes in Working Capital
17,678.00
49,546.00
22,872.00
2,855.00
17,276.00
Net Operating Cash Flow
80,927.00
49,234.00
71,966.00
37,180.00
67,339.00
Capital Expenditures
716.00
730.00
1,265.00
4,062.00
-
Sale of Fixed Assets & Businesses
18.00
2.00
41.00
25.00
1,225.00
Purchase/Sale of Investments
49,891.00
10,751.00
9,225.00
32,032.00
13,175.00
Net Investing Cash Flow
49,193.00
11,479.00
8,001.00
27,995.00
14,400.00
Issuance/Reduction of Debt, Net
9,192.00
9,192.00
-
10,000.00
10,000.00
Net Financing Cash Flow
132,984.00
1,084.00
54,805.00
23,111.00
9,729.00
Net Change in Cash
101,250.00
61,797.00
9,160.00
13,926.00
62,668.00
Free Cash Flow
81,643.00
49,964.00
73,231.00
41,242.00
67,339.00
Change in Capital Stock
123,792.00
8,108.00
54,805.00
13,111.00
271.00

About Affymax

View Profile
Address
630 Fifth Avenue
New York New York 10020
United States
Employees -
Website http://www.affymax.com
Updated 07/08/2019
Affymax, Inc. is a biopharmaceutical company. The company was founded on July 20, 2001 and is headquartered in New York, NY. .